+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nebulizer Market by Type, Application, End User, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717223
The nebulizer market size is estimated to be USD 1,107.1 million in 2022 and is expected to witness a CAGR of 5.98% during the forecast period 2023-2033. Rising initiatives by market players to increase public awareness of the various alternative treatments for respiratory disorders and surge in the prevalence of asthma are some of the factors contributing to the market growth. Furthermore, escalating demand for home healthcare equipment and ageing population are other factors supporting the market growth. However, presence of nebulizer alternatives is expected to hinder the growth.

Rising initiatives by market players to increase public awareness of the various alternative treatments for respiratory disorders is expected to fuel the market growth during the projected period. For instance, Cipla Limited announced a first effort in December 2021 to improve access to nebulization therapy especially for patients in India's rural areas. In addition, OMRON will create Experience Centers with customer service contact points in important Indian cities to give customers first-hand exposure to OMRON products and increase consumer awareness of nebulizer effectiveness.

Surge in the prevalence of asthma is predicted to propel the market growth during the forecast period. For instance, according to data from state and national surveillance systems operated by the Centers for Disease Control and Prevention (CDC), 25,257,138 people had asthma prevalence in May of 2020. In addition, the American Cancer Society predicted that there were 236,740 new cases of lung and bronchus cancer in the US in 2022. Nebulizers are required due to the increased prevalence of lung cancer, asthma, and other respiratory diseases which in turn fuels the market's expansion.

Segmentation

By Type

The market is categorized into ultrasonic, jet, and mesh. In 2022, the jet segment accounted for the highest revenue share due to their low price. Additionally, the ease of using nebulizers and their effective design for drug administration have elevated jet nebulizers to the top of the market over time. Jet nebulizers can effectively deliver medicines that pressured metered-dose inhalers and dry powder inhalers cannot. Nebulizers can also be found in a wide range of types such as jet nebulizers, collection bags, breath-enhanced, corrugated tubes, and breath-actuated jet nebulizers, among others. The mesh nebulizers market segment is anticipated to have profitable market expansion throughout the forecast period due to the technologically improved, small-sized devices, and reduced drug loss. The mesh nebulizer market is anticipated to expand further due to rising patient acceptance, rapid healing, mobility, and convenience.

By Application

The market is divided into asthma, COPD, cystic fibrosis, and others. In the global market, the segment accounted for the largest revenue share in 2022 owing to rising prevalence of COPD. Nebulizers are more patient-friendly and portable due to recent advancements in technology. Long-acting beta2-agonists (LABAs), steroids, mucolytics, long-acting muscarinic receptor antagonists, and antibiotics are also frequently available as nebulized formulations. The segment is growing due to the fact that these characteristics enable COPD patients to use nebulizers outside of acute settings including clinics or hospitals. For instance, Wellinks announced in January 2021 that a U.S. FDA review group has approved the use of the wireless nebulizer for people with COPD. Wellinks' objective is to improve respiratory care for the general public. The asthma segment is anticipated to have profitable market expansion over the projected period. Some of the factors promoting the segment's growth include the rising prevalence of asthma on a global scale, along with government agencies and nongovernmental organization (NGO) operations for raising awareness.

By End User

The market is segmented into home healthcare, hospitals, and clinics, and emergency centers. In 2022, the hospitals segment accounted for the largest revenue share owing to favourable reimbursement policies and rising patient traffic. As a result, companies make significant investments in their marketing plans and financial resources to promote their products and services among hospitals. Additionally, Cipla Limited announced a project in December 2021 to improve access to nebulization therapy for acute asthma management in primary healthcare facilities in rural India. Thus, these initiatives foster segment growth. Home healthcare segment is anticipated to expand at the fastest rate during the forecast period due to product miniaturization and technological developments. In addition, the rising prevalence of target diseases, ageing population, and the demand to reduce healthcare spending are anticipated to be some of the key factors driving the need for home healthcare devices. The nebulizer industry is anticipated to grow as home healthcare becomes more affordable as a substitute for costly hospital stays.

Regional Markets

In 2022, North America region accounted for the highest revenue in the nebulizer market and is expected to maintain its dominance during the forecast period. This is attributed to the rising respiratory disorders and government initiatives including attractive reimbursement scenarios, consumer awareness, and strong healthcare infrastructure. In addition, favourable reimbursement policies and the launch of technologically improved gadgets are anticipated to support market expansion in this region. Additionally, the U.S.'s growing geriatric population is causing a growth in surgeries worldwide which is fueling the expansion of the local market. However, Asia Pacific is predicted to have the fastest growing market over the projection period due to the large ageing population, growing emphasis on preventative care, and government initiatives supporting technology advancements. Foreign players have been successfully drawn to this market by the region's governments' advantageous tax laws and low-cost manufacturing facilities.

Competitor Insights

Some of the key players operating in the nebulizer market are PARI Respiratory Equipment, Inc., Allied Healthcare, GE Healthcare, Vectura Group Plc., DeVilbiss Healthcare LLC, Briggs Healthcare, Aerogen, Omron Corporation, Koninklijke Philips N.V., and Beurer GmBH.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, in March 2021, the LAMIRA Nebulizer System was approved in Japan by PARI Pharma GmbH, a company specializing in cutting-edge aerosol delivery systems based on eFlow Technology. As it is appropriate for delivering ARIKAYCE, the LAMIRA Nebulizer System is the only device made for the purpose.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including type, application and end user from 2023 to 2033.

Segmentation: Nebulizer Market Report 2022 - 2033

Type (Revenue, USD Million), 2022 - 2033

  • Ultrasonic
  • Jet

Mesh

  • Active
  • Passive

Application (Revenue, USD Million), 2022 - 2033

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Others

End user (Revenue, USD Million), 2022 - 2033

  • Home Healthcare
  • Hospitals and Clinics
  • Emergency Centers

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Nebulizer

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Nebulizer Market

7. Market Analysis by Type
7.1. Ultrasonic
7.1.1. Ultrasonic Market Forecast, 2022-2033 (USD Million)
7.2. Jet
7.2.1. Jet Market Forecast, 2022-2033 (USD Million)
7.3. Mesh
7.3.1. Mesh Market Forecast, 2022-2033 (USD Million)
7.3.1.1. Active
7.3.1.1.1. Active Market Forecast, 2022-2033 (USD Million)
7.3.1.2. Passive
7.3.1.2.1. Passive Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Application
8.1. Asthma
8.1.1. Asthma Market Forecast, 2022-2033 (USD Million)
8.2. COPD
8.2.1. COPD Market Forecast, 2022-2033 (USD Million)
8.3. Cystic Fibrosis
8.3.1. Cystic Fibrosis Market Forecast, 2022-2033 (USD Million)
8.4. Others
8.4.1. Others Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by End User
9.1. Home Healthcare
9.1.1. Home Healthcare Market Forecast, 2022-2033 (USD Million)
9.2. Hospitals and Clinics
9.2.1. Hospitals and Clinics Market Forecast, 2022-2033 (USD Million)
9.3. Emergency Centers
9.3.1. Emergency Centers Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends Analysis

9. North America Nebulizer Market
9.1. North America Nebulizer Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
9.2. U.S. Nebulizer Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
9.3. Canada Nebulizer Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

10. Europe Nebulizer Market
10.1. Europe Nebulizer Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.2. Germany Nebulizer Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.3. UK Nebulizer Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.4. France Nebulizer Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.5. Spain Nebulizer Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.6. Italy Nebulizer Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
10.7. Rest of Europe Nebulizer Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

11. Asia Pacific Nebulizer Market
11.1. Asia Pacific Nebulizer Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.2. Japan Nebulizer Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.3. China Nebulizer Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.4. India Nebulizer Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.5. South Korea Nebulizer Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.6. Australia Nebulizer Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Nebulizer Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

12. Latin America Nebulizer Market
12.1. Latin America Nebulizer Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.2. Brazil Nebulizer Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.3. Mexico Nebulizer Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.4. Argentina Nebulizer Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
12.5. Rest of Latin America Nebulizer Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

13. MEA Nebulizer Market
13.1. MEA Nebulizer Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.2. GCC Nebulizer Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.3. South Africa Nebulizer Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)
13.4. Rest of MEA Nebulizer Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by End User, 2022-2033 (USD Million)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. PARI Respiratory Equipment, Inc.
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Analysis
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. Allied Healthcare
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Analysis
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. GE Healthcare
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Analysis
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Vectura Group Plc.
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Analysis
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. DeVilbiss Healthcare LLC
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Analysis
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. Briggs Healthcare
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Analysis
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Aerogen
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Analysis
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. Omron Corporation
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Analysis
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. Koninklijke Philips N. V.
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Analysis
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. Beurer GmBH
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Analysis
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. Company 11
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financial Analysis
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Company 12
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financial Analysis
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Company 13
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financial Analysis
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Company 14
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financial Analysis
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financial Analysis
15.15.4. Product Benchmarking
15.15.5. Recent Developments

16. Conclusion

17. Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • PARI Respiratory Equipment Inc.
  • Allied Healthcare
  • GE Healthcare
  • Vectura Group Plc.
  • DeVilbiss Healthcare LLC
  • Briggs Healthcare
  • Aerogen
  • Omron Corporation
  • Koninklijke Philips N.V.
  • Beurer GmBH.